Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06887829 · ClinicalTrials.gov registry record · NA

Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial

A NA study of Osteoarthritis, Knee, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT06887829 is a NA study of Osteoarthritis, Knee that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 128 participants, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06887829, a NA study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to investigate whether low-dose radiotherapy is an effective treatment to reduce the pain of knee osteoarthritis. A secondary aim is to determine whether patients experience any more measurable side effects than those receiving sham treatments.

Conditions Studied

Interventions

  • RADIATION Low dose radiotherapy
  • OTHER Sham comparator

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2025-06-04
Est. Completion 2026-06-29
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06887829

The ClinicalTrials.gov registry entry for NCT06887829 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (78% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which Low dose radiotherapy is the first listed.

NCT06887829 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06887829 about?

NCT06887829 is a clinical study titled "Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial". The primary aim of this study is to investigate whether low-dose radiotherapy is an effective treatment to reduce the pain of knee osteoarthritis. A secondary aim is to determine whether patients experience any more measurable side effects than those receiving sham treatments.

What is the current status of trial NCT06887829?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-06-04. Estimated completion is 2026-06-29.

What conditions does trial NCT06887829 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT06887829?

The interventions under investigation include: Low dose radiotherapy (RADIATION), Sham comparator (OTHER).

Who is sponsoring clinical trial NCT06887829?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06887829 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.